Yangsen Cao
Overview
Explore the profile of Yangsen Cao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
243
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang L, Ye Y, Feng Z, Liu W, Cao Y, Zhao X, et al.
Radiat Oncol
. 2024 Aug;
19(1):111.
PMID: 39160547
Background: Local therapies may benefit patients with oligometastatic cancer. However, there were limited data about pancreatic cancer. Here, we compared the efficacy and safety of stereotactic body radiation therapy (SBRT)...
2.
Fang F, Jia Z, Xie H, Cao Y, Zhu X, Yang X, et al.
Clin Respir J
. 2024 Apr;
18(5):e13749.
PMID: 38685745
Background And Objective: The neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) were significant and succinct indicators of systemic inflammation. We assessed the influence of stereotactic body radiotherapy (SBRT) on NLR...
3.
Zhang F, Wang D, Cannone Falchetto A, Cao Y
Sci Total Environ
. 2023 Dec;
912:169189.
PMID: 38097074
A large amount of solid waste, such as steel slag (SS), is generated annually. At the same time, the shortage of road construction materials is becoming a concern. In this...
4.
Jia Z, Fang F, Cao Y, Zhu X, Yang X, Guo X, et al.
Radiat Oncol
. 2023 Oct;
18(1):169.
PMID: 37821978
No abstract available.
5.
Zhu X, Liu W, Cao Y, Feng Z, Zhao X, Jiang L, et al.
Radiother Oncol
. 2023 Oct;
190:109941.
PMID: 37820884
Purpose: Immunotherapy alone offered limited survival benefits in pancreatic cancer, while the role of immunotherapy-centric combined therapy remains controversial. Therefore, it is required to develop biomarkers to precisely deliver immunotherapy-based...
6.
Jia Z, Fang F, Cao Y, Zhu X, Yang X, Guo X, et al.
Radiat Oncol
. 2023 Aug;
18(1):140.
PMID: 37620952
Background: In this study, we evaluated the efficacy and toxicity of stereotactic body radiotherapy (SBRT) as replacement strategy of conventionally fractionated radiation therapy in stage III non-small cell lung cancer...
7.
Cao Y, Zhu X, Yu C, Jiang L, Sun Y, Guo X, et al.
Front Oncol
. 2023 Feb;
12:1021058.
PMID: 36793343
Purpose: Re-irradiation of locally recurrent pancreatic cancer may be an optimal choice as a local ablative therapy. However, dose constraints of organs at risk (OARs) predictive of severe toxicity remain...
8.
Zhao X, Zhu X, Cheng C, Jiang L, Ye Y, Cao Y, et al.
Future Oncol
. 2022 Dec;
PMID: 36507781
To explore the safety and efficacy of the integrated boost to the dominant intraprostatic nodule (DIN) based on Ga prostate-specific membrane antigen PET/MRI in stereotactic body radiation therapy (SBRT) for...
9.
Zhu X, Liu W, Cao Y, Ju X, Zhao X, Jiang L, et al.
EClinicalMedicine
. 2022 Dec;
55:101764.
PMID: 36471691
Background: There are a lack of studies about whether radiation dose escalation synergizes with immunotherapy and targeted therapy in pancreatic cancer. In this study, we performed a secondary analysis to...
10.
Cao Y, Li X, Liu Z, Li J, Zhang F, Shan B
Materials (Basel)
. 2022 Oct;
15(19).
PMID: 36234058
The traditional method of removing ice and snow on roads carries the risk of damaging roads and the environment. In this circumstance, the technology of salt-storage asphalt pavement has gradually...